Biomarkers of fibrosis, inflammation, and extracellular matrix in the phase 3 trial of tocilizumab in systemic sclerosis
Xin Sheng, Xia Gao, Courtney Schiffman, Jenny Jiang, Thirumalai R. Ramalingam, Celia J. F. Lin, Dinesh Khanna, Margaret Neighbors
Topics & Concepts
PeriostinTocilizumabMedicineFibrosisBiomarkerExtracellular matrixInflammationScleroderma (fungus)Internal medicineMatricellular proteinSystemic inflammationImmunologyGastroenterologyRheumatoid arthritisBiologyBiochemistryCell biologyInoculationSystemic Sclerosis and Related DiseasesInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisDermatologic Treatments and Research